In Vitro Antifungal Activity of (1)- N -2-Methoxybenzyl-1,10-phenanthrolinium Bromide against Candida albicans and Its Effects on Membrane Integrity
Metal-based drugs, such as 1,10-phenanthroline, have demonstrated anticancer, antifungal and antiplasmodium activities. One of the 1,10-phenanthroline derivatives compounds (1)- -2-methoxybenzyl-1,10-phenanthrolinium bromide (FEN), which has been demonstrated an inhibitory effect on the growth of sp...
Saved in:
Published in | Mycobiology Vol. 45; no. 1; pp. 25 - 30 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
The Korean Society of Mycology
01.03.2017
한국균학회 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Metal-based drugs, such as 1,10-phenanthroline, have demonstrated anticancer, antifungal and antiplasmodium activities. One of the 1,10-phenanthroline derivatives compounds (1)-
-2-methoxybenzyl-1,10-phenanthrolinium bromide (FEN), which has been demonstrated an inhibitory effect on the growth of
spp. This study aimed to explore the
antifungal activity of FEN and its effect on the membrane integrity of
. The minimum inhibitory concentration (MIC) and the minimum fungicidal concentration (MFC) of FEN against planktonic
cells were determined using the broth microdilution method according to the Clinical and Laboratory Standards Institute guidelines. Cell membrane integrity was determined with the propidium iodide assay using a flow cytometer and were visualized using scanning electron microscopy (SEM). Planktonic cells growth of
were inhibited by FEN, with an MIC of 0.39-1.56 µg/mL and a MFC that ranged from 3.125 to 100 µg/mL. When
was exposed to FEN, the uptake of propidium iodide was increased, which indicated that membrane disruption is the probable mode of action of this compound. There was cells surface changes of
when observed under SEM. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 G704-001049.2017.45.1.003 |
ISSN: | 1229-8093 2092-9323 |
DOI: | 10.5941/myco.2017.45.1.25 |